- Home
- MRNA vs RTO Comparison
MRNA vs RTO Comparison
Compare MRNA & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- RTO
- Stock Information
- Founded
- MRNA 2010
- RTO 1925
- Country
- MRNA United States
- RTO United Kingdom
- Employees
- MRNA N/A
- RTO N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- RTO Business Services
- Sector
- MRNA Health Care
- RTO Consumer Discretionary
- Exchange
- MRNA Nasdaq
- RTO Nasdaq
- Market Cap
- MRNA 16.0B
- RTO 13.1B
- IPO Year
- MRNA 2018
- RTO N/A
- Fundamental
- Price
- MRNA $34.06
- RTO $23.85
- Analyst Decision
- MRNA Hold
- RTO Hold
- Analyst Count
- MRNA 20
- RTO 2
- Target Price
- MRNA $76.35
- RTO $29.00
- AVG Volume (30 Days)
- MRNA 10.7M
- RTO 595.1K
- Earning Date
- MRNA 02-20-2025
- RTO 01-28-2025
- Dividend Yield
- MRNA N/A
- RTO 2.44%
- EPS Growth
- MRNA N/A
- RTO 24.34
- EPS
- MRNA N/A
- RTO 0.20
- Revenue
- MRNA $5,081,000,000.00
- RTO $6,837,109,965.00
- Revenue This Year
- MRNA N/A
- RTO $4.06
- Revenue Next Year
- MRNA N/A
- RTO $2.81
- P/E Ratio
- MRNA N/A
- RTO $23.88
- Revenue Growth
- MRNA N/A
- RTO 12.40
- 52 Week Low
- MRNA $31.94
- RTO $22.40
- 52 Week High
- MRNA $170.47
- RTO $34.07
- Technical
- Relative Strength Index (RSI)
- MRNA 34.88
- RTO 39.23
- Support Level
- MRNA $33.34
- RTO $23.25
- Resistance Level
- MRNA $35.68
- RTO $23.95
- Average True Range (ATR)
- MRNA 2.46
- RTO 0.42
- MACD
- MRNA -0.75
- RTO -0.09
- Stochastic Oscillator
- MRNA 12.49
- RTO 25.64
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.